Latest Articles about ACT

Random Thoughts: The Chasm Between Stocks and Commodities Continues to Widen

Todd Harrison — Wed, 22 May 2013 22:18:00 Z

Editor's Note: Todd posts his vibes in real time each day on our Buzz & Banter . Who knows how long this will last; now we've come so far, so fast. -- Don Henley Greetings

Actavis to Buy Warner Chilcott - Analyst Blog

Zacks Equity Research — Wed, 22 May 2013 00:25:25 Z

Actavis, Inc. ( ACT ) recently announced its intention to acquire Warner Chilcott plc ( WCRX ) in a stock-for-stock transaction worth about $8.5 billion. This includes the assumption of

Stock Market News for May 21, 2013 - Market News

Zacks Equity Research — Tue, 21 May 2013 18:30:15 Z

Investors grew cautious on Monday owing to fears over a correction and a Federal Reserve official's comments on monetary stimulus. Encouraging developments on corporate acquisitions could not

FDA Accepts Actavis NDA - Analyst Blog

Zacks Equity Research — Mon, 20 May 2013 20:05:55 Z

The US Food and Drug Administration (FDA) recently accepted Actavis, Inc.'s ( ACT ) new drug application for its oral contraceptive candidate. The company is looking to get its

Pre-Market Most Active for May 20, 2013 : WCRX, RDS/B, YHOO, ACT, BAC, BP, AU, NBG, GILD, ASML, WBSN, ZNGA

NASDAQ.com News — Mon, 20 May 2013 16:39:56 Z

The NASDAQ 100 Pre-Market Indicator is to 3,026.98. The total Pre-Market volume is currently 9,282,494 shares traded. The following are the most active stocks for the pre-market session :

Earnings Beat at Warner Chilcott - Analyst Blog

Zacks Equity Research — Mon, 13 May 2013 18:48:01 Z

Warner Chilcott' s ( WCRX ) first quarter 2013 earnings (excluding special items) of 92 cents per share handsomely beat the Zacks Consensus Estimate of 85 cents. Lower selling, general

Earnings Beat at Endo Health, Sales Slip - Analyst Blog

Zacks Equity Research — Thu, 09 May 2013 02:24:39 Z

Endo Health Solutions' ( ENDP ) first quarter 2013 earnings (excluding special items) of $1.09 per share beat the Zacks Consensus Estimate by a penny and increased 25% from the year-ago

Earnings Miss at Perrigo - Analyst Blog

Zacks Equity Research — Tue, 07 May 2013 20:24:49 Z

Perrigo Company 's ( PRGO ) third quarter fiscal 2013 (ended Mar 30, 2013) earnings of $1.42 per share fell short of the Zacks Consensus Estimate by 2 cents. Lower-than-expected revenues

Acorda Incurs Loss, Maintains Guidance - Analyst Blog

Zacks Equity Research — Mon, 06 May 2013 23:25:55 Z

Acorda Therapeutics Inc. 's ( ACOR ) first quarter 2013 loss (including share-based compensation charges but excluding other special items) of 3 cents per share compared unfavorably with

Perrigo Likely to Report In Line Earnings - Analyst Blog

Mark Vickery — Mon, 06 May 2013 23:23:50 Z

We expect Perrigo Company ( PRGO ) to report in line third quarter fiscal 2013 results before the opening bell on May 7. The company's fiscal year ends on the last Saturday of Jun every

Company News for May 3, 2013 - Corporate Summary

Zacks Equity Research — Fri, 03 May 2013 17:29:42 Z

• Actavis Inc (NYSE: ACT ) reported first quarter earnings per share of $1.99, beating the Zacks Consensus Estimate of $1.87 • BEAM Inc (NYSE: BEAM ) posted first quarter earnings per

Actavis Beats on Earnings, Raises View - Analyst Blog

Zacks Equity Research — Thu, 02 May 2013 17:55:40 Z

Actavis, Inc.'s ( ACT ) first quarter 2013 earnings of $1.99 per share beat the Zacks Consensus Estimate of $1.87 and increased 21% from the year-ago earnings. Revenues for the reported

Shire Settles Lawsuit with Actavis - Analyst Blog

Zacks Equity Research — Wed, 01 May 2013 21:48:50 Z

Shire ( SHPG ) recently announced that the company settled its pending litigation with Actavis, Inc ( ACT ), formerly known as Watson Pharmaceuticals. The litigation was primarily

Canadian Stocks Edging Higher, Bit By Bit; Mining, Energy Stocks Pacing Gains For Toronto Stock Market

MidnightTrader.com Staff — Mon, 29 Apr 2013 21:48:20 Z

Canadian stocks are edging up bit by bit as the day goes on today, with the S&P Composite Index now up more than 90 points, or about 0.75%. Trading has been fairly steady in the afternoon

Pre-Market Primer: Consumer Spending and Income Mark Tepid Rise

Vincent Trivett — Mon, 29 Apr 2013 16:47:00 Z

Gold and stocks rallied this morning as the dollar weakened and consumer spending figures came in slightly better than expected. Consumer spending, the heartbeat of the American economy, grew